What is Sequel?
Founded by award-winning Stanford engineers and former athletes Greta Meyer and Amanda Calabrese, Sequel has engineered a redesigned tampon aimed at enhanced reliability, comfort, and absorption efficiency. The company operates within the rapidly evolving femtech and consumer health markets, addressing a fundamental need with advanced product design and engineering. Their approach seeks to elevate the user experience and product performance in a category ripe for innovation.
How much funding has Sequel raised?
Sequel has raised a total of $5M across 1 funding round:
Angel/Seed
$5M
Angel/Seed (2021): $5M with participation from Pear, MaC VC, Ulu Ventures, Long Journey Ventures, and Graph Ventures
Key Investors in Sequel
Pear
Pear VC is an early-stage investment firm that supports pre-seed and seed companies, offering expertise in talent recruitment, fundraising, and go-to-market strategies. They have a strong track record of seeding high-growth startups.
Ulu Ventures
Ulu Ventures is a Silicon Valley-based venture capital firm that prioritizes investments in women and diverse founder teams, focusing on seed-stage companies with significant market potential. They employ a data-driven approach to identify promising ventures.
Long Journey Ventures
Long Journey Ventures specializes in early-stage investments, embracing unconventional ideas and supporting founders with a nurturing, direct mentorship approach. They value integrity and long-term growth for their portfolio companies.
What's next for Sequel?
With the recent infusion of capital, Sequel is poised for significant expansion and product development. The major strategic investment suggests a focus on scaling operations, potentially increasing manufacturing capacity, and broadening market reach. Future endeavors will likely involve further research and development to maintain their competitive edge, alongside strategic marketing initiatives to capture a larger share of the menstrual hygiene market. The company's trajectory indicates a move towards solidifying its position as a leader in advanced feminine care solutions.
See full Sequel company page